NDI-034858
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NDI-034858, covering 2023-09-28 to 2024-05-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis [Phase 2]